Safety study of a new oral tablet in healthy volunteers
This early-phase study tests a new oral tablet (YR011) in healthy volunteers to see how safe it is and how the body processes it. It helps find the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your weight is less than 120 kg and your body mass index (BMI) is between 18 and 32.
- You are generally healthy, with no major medical conditions like heart, liver, kidney, or thyroid problems, diabetes, or a history of cancer.
- If you are a man, you must use a condom or not have sex during the study and for 3 months after the last dose.
- If you are a woman who could become pregnant, you must use highly effective birth control and your partner must also use a condom during the study and for 3 months after.
- You are not taking any other medications (including over-the-counter drugs, herbs, or supplements) for 14 days before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This phase 1 study tests a new medicine called YD0293 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
This study tests a new tablet called VV261 in healthy volunteers. It looks at how the drug moves through the body and how safe it is when taken multiple times. It may help show if the drug is promising for future treatments.
Hear when a new Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.